ReviewJournal of applied toxicology : JAT2026
Understanding Chlorfenapyr Toxicity: An Overview of Acute Human Exposure and Clinical Outcomes.
Review in Journal of applied toxicology : JAT, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chlorfenapyr is a broad-spectrum pyrrole insecticide. It acts as a pro-insecticide and is metabolized to tralopyril. Acute human chlorfenapyr poisoning is poorly understood, and optimal management after acute exposure is unclear. This review characterizes acute chlorfenapyr poisoning in humans, focusing on its mechanisms, clinical presentation, laboratory findings, imaging results, and treatment strategies. Fifty-six articles were identified. We conducted a literature review using PubMed, Web of Science, Google Scholar, and SpringerLink databases. Chlorfenapyr poisoning can have a latency period of up to 14 days and may cause gradual deterioration over several hours to days, leading to significant morbidity and even death. A serious clinical sign is the development of hyperthermia, likely due to the uncoupling of oxidative phosphorylation by tralopyril. Chlorfenapyr poisoning is characterized by delayed neurological symptoms and a high mortality rate. Laboratory tests often reveal elevated levels of creatine kinase, hepatic aminotransferases, and lactate dehydrogenase. To date, no specific antidotes are available, and treatment remains supportive. When managing cases of acute chlorfenapyr poisoning, physicians must consider the potential latent period of the toxin's effects. This means that even if a patient shows an initial positive response to treatment, healthcare providers should remain vigilant and cannot assume that the patient is completely safe. Continuous monitoring and assessment are essential, as symptoms may still emerge after the initial treatment phase.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.